3′-Fluoro-3′-deoxy-5′-noraristeromycin derivatives: Synthesis and antiviral analysis

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 14, 2006, Pages 4980-4986

  Roy, Atanu ^a   Serbessa, Tesfaye ^a   Schneller, Stewart W ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

DAST; Difluoromethylene; Fluoro carbocyclic nucleosides

Indexed keywords

3' FLUOR 3' DEOXYADENOSINE; 3' FLUORO 3' DEOXY 5' NORARISTEROMYCIN DERIVATIVE; ADENOSINE; ANTIVIRUS AGENT; UNCLASSIFIED DRUG; ARISTEROMYCIN; DRUG DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ANIMAL; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; HUMAN; IN VITRO STUDY; MICROBIOLOGICAL EXAMINATION; STRUCTURE ACTIVITY RELATION; SYNTHESIS; VIRUS;

ADENOSINE; ANIMALS; ANTIVIRAL AGENTS; DRUG DESIGN; HUMANS; MICROBIAL SENSITIVITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUSES;

EID: 33646786050     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.03.011     Document Type: Article

References (19)

1. Wolfe M.S., and Borchardt R.T. J. Med. Chem. 34 (1991) 1521-1530
2. De Clercq E. Nucleosides Nucleotides Nucleic Acids 24 (2005) 1395-1415
3. For a leading reference see. Yin X., and Schneller S.W. Nucleosides Nucleotides Nucleic Acids 23 (2004) 67-76
4. For a leading reference see. Xu F., Simmons B., Armstrong III J., and Murry J. J. Org. Chem. 70 (2005) 6105-6107
5. Van Aerschot A., Herdewijn P., Janssen G., Cools M., and De Clercq E. Antiviral Res. 12 (1989) 133-150
6. Mikhailopulo I.A., Poopeiko N.E., Pricota T.I., Sivets G.G., Kvasyuk E.I., Balzarini J., and De Clercq E. J. Med. Chem. 34 (1991) 2195-2202
7. For example,. Yin X.-q., and Schneller S.W. Tetrahedron Lett. 46 (2005) 7535-7538
8. Moon H.R., Lee K.M., Lee H.J., Lee S.K., Park S.B., Chun M.W., and Jeong L.S. Nucleosides Nucleotides Nucleic Acids 24 (2005) 707-708
9. Roy A., Schneller S.W., Keith K.A., Hartline C.B., and Kern E.R. Bioorg. Med. Chem. 13 (2005) 4443-4449
10. Siddiqi S.M., Chen X., and Schneller S.W. Nucleosides Nucleotides 12 (1993) 267-278
11. Hillman J.M.L., and Roberts S.M. J. Chem. Soc. Perkin Trans. 1 (1997) 3601-3608
12. 8 because of its greater stability to many reagents. Greene T.W., and Wuts P.G.M. Protective Groups in Organic Synthesis (1999), John Wiley, New York 141
13. Simas A.B.C., Pais K.C., and Da Silva A.A.T. J. Org. Chem. 68 (2003) 5426-5428
14. Maruyama T., Takamatsu S., Kozai S., Satoh Y., and Izawa K. Chem. Pharm. Bull. 47 (1999) 966-970
15. Sutherland A., and Vederas J.C. J. Chem. Soc., Chem. Commun. (1999) 1739-1740
16. For leading references on the procedures used for the assays, see. Rajappan V.P., Schneller S.W., Williams S.L., and Kern E.R. Bioorg. Med. Chem 10 (2002) 883-886
17. Siddiqi S.M., Chen X., Schneller S.W., Ikeda S., Snoeck R., Andrei G., Balzarini J., and De Clercq E. J. Med. Chem 37 (1994) 551-554
18. Chu C.K., Jin Y.H., Baker R.O., and Huggins J. Bioorg. Med. Chem. Lett. 13 (2003) 9-12
19. (January 27, 2006).